How should I assess multiple painful yellow vesicles on the labia minora in a child‑bearing‑age woman with persistent Candida glabrata infection and a missed period?

Assessment of Multiple Yellowish Blisters on Labia Minora with Persistent C. glabrata and Missed Period

This presentation requires immediate exclusion of herpes simplex virus (HSV) infection first, followed by pregnancy testing, before addressing the persistent C. glabrata infection—the yellowish vesicles are NOT typical of candidiasis and suggest an alternative diagnosis.

Critical Differential Diagnosis

The clinical presentation of multiple painful yellow vesicles is highly atypical for vulvovaginal candidiasis, which typically presents with erythema, edema, excoriation, fissures, and white curd-like discharge—not vesicles 1. This discordance demands consideration of:

Primary Concern: Herpes Simplex Virus

• Vesicular lesions are the hallmark of HSV, not Candida 2
• HSV presents with painful vesicles that may appear yellowish when filled with purulent material
• The missed period raises pregnancy concerns, making HSV diagnosis critical (neonatal transmission risk)
• Obtain viral culture or PCR from vesicle fluid immediately 2

Secondary Consideration: Pregnancy Status

• Perform urine or serum β-hCG immediately given the missed period
• Pregnancy alters treatment options for both HSV and C. glabrata
• Pregnancy is associated with increased VVC but does not cause vesicular lesions 3

Rare Alternative: Lymphangioma Circumscriptum

• Can present as grouped vesicles on vulva, though typically painless 4
• Requires histopathological confirmation
• Consider if HSV testing is negative

Management of Persistent C. glabrata Infection

For confirmed C. glabrata vulvovaginitis unresponsive to azoles, use intravaginal boric acid 600 mg daily for 14 days 1.

Treatment Algorithm for C. glabrata:

1. First-line therapy: Boric acid gelatin capsules 600 mg intravaginally daily × 14 days 1

2. Alternative options if boric acid fails or is unavailable:

   • Nystatin suppositories 100,000 units daily × 14 days 1
   • Compounded 17% flucytosine cream ± 3% amphotericin B cream daily × 14 days 1, 5

3. Avoid azole monotherapy (fluconazole, voriconazole) as C. glabrata shows frequent azole resistance 1, 5, 6

If Pregnancy is Confirmed:

• Boric acid is contraindicated in pregnancy
• Use topical azole therapy for 7 days despite reduced efficacy 5
• Consider nystatin as safer alternative
• Close monitoring required given treatment limitations

Critical Pitfalls to Avoid

Do not assume the vesicles are related to Candida—this is the most dangerous error. Candida does not cause vesicles; missing HSV in a potentially pregnant patient has severe consequences for both mother and neonate.

Do not continue azole therapy for confirmed C. glabrata—this species has intrinsic reduced azole susceptibility, and continued azole use promotes further resistance 6, 7.

Do not delay pregnancy testing—treatment options differ significantly, and some therapies (boric acid) are contraindicated in pregnancy.

Immediate Action Steps

1. Unroof a vesicle and obtain fluid for HSV PCR/culture 2
2. Perform pregnancy test (urine β-hCG)
3. Obtain vaginal culture with Candida speciation to confirm C. glabrata (not just assume based on history)
4. Examine for other STIs as HSV and other pathogens can coexist 2

Once HSV is excluded and pregnancy status determined, proceed with appropriate C. glabrata therapy based on the algorithm above. If HSV is confirmed, initiate acyclovir or valacyclovir immediately, with dosing adjusted for pregnancy status if applicable.